IFF
44
3
EQT
34
-8
GE
55
4
EMR
50
2
NSC
27
-3
CLX
63
4
NEE
34
-2
AVB
47
-2
SWKS
51
6
ADI
49
-2
MMM
32
6
WEC
36
5
BAX
35
2
WBA
38
-2
PPL
35
6
TJX
47
-4
PNC
42
-3
INTC
31
2
CNP
42
4
BLK
44
-11
IFF
44
3
EQT
34
-8
GE
55
4
EMR
50
2
NSC
27
-3
CLX
63
4
NEE
34
-2
AVB
47
-2
SWKS
51
6
ADI
49
-2
MMM
32
6
WEC
36
5
BAX
35
2
WBA
38
-2
PPL
35
6
TJX
47
-4
PNC
42
-3
INTC
31
2
CNP
42
4
BLK
44
-11
Financhill
Back

LeMaitre Vascular Vs. Perspective Therapeutics Industry Stock Comparison

Buy
56

LMAT
LeMaitre Vascular

Last Price:
$92.19
Seasonality Move:
0.67%
Sell
23

CATX
Perspective Therapeutics

Last Price:
$2.87
Seasonality Move:
27.93%
Buy
56
LeMaitre Vascular (LMAT) is a Buy

Is LeMaitre Vascular a Buy, Sell or Hold?

  • The current LeMaitre Vascular [LMAT] share price is $92.25. The Score for LMAT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • LMAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
23
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $2.84. The Score for CATX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

LMAT Stock Price Chart

What is LeMaitre Vascular's stock price today?

  • The LeMaitre Vascular share price today is $92.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LMAT is experiencing buying pressure, which is a positive indicator for future bullish movement.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $2.84
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight selling pressure.

LMAT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.92 Sell
Relative Strength Index (14 RSI): 36.4 Sell
Chaikin Money Flow: 211917 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (96.37 - 106.55) Sell
Bollinger Bands (100): (85.25 - 99.85) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.44 Sell
Relative Strength Index (14 RSI): 19.16 Sell
Chaikin Money Flow: -272874 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.78 - 5.96) Sell
Bollinger Bands (100): (6.89 - 15.07) Sell

LMAT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.86 Sell
20-day SMA: 101.12 Sell
50-day SMA: 97.45 Sell
200-day SMA: 83.63 Buy
8-day EMA: 94.97 Sell
20-day EMA: 98.29 Sell
50-day EMA: 97.37 Sell
200-day EMA: 85.09 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.3 Sell
20-day SMA: 3.63 Sell
50-day SMA: 8.19 Sell
200-day SMA: 12.23 Sell
8-day EMA: 3.28 Sell
20-day EMA: 4.34 Sell
50-day EMA: 7.14 Sell
200-day EMA: 10.09 Sell

LeMaitre Vascular Earnings Growth & LMAT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.61 per share, and an increase next year of $0.22 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

LeMaitre Vascular Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):